The use of respiratory system medicine in Sweden is forecasted to increase steadily from 2024 to 2028. The data shows a consistent year-on-year growth, indicating a rising dependency on these medications. Specifically, the projected usage values rise from 248.1 Units per Thousand Persons per Day in 2024 to 281.4 in 2028. The year-on-year variations are about 3.4% for 2025, 3.3% for 2026, 3.1% for 2027, and 3.0% for 2028. The compound annual growth rate (CAGR) over these five years is around 3.2%.
Future trends to watch for:
- Increasing awareness and diagnostics of respiratory conditions, which could further drive medicine usage.
- Advances in medication and treatment options that may affect usage patterns, either increasing or curbing the growth.
- Potential impact of public health initiatives aimed at reducing respiratory ailments through environmental and lifestyle changes.
